Characterisation of an engineered trastuzumab IgE antibody and effector cell mechanisms targeting HER2/neu-positive tumour cells. (Q34475414)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Characterisation of an engineered trastuzumab IgE antibody and effector cell mechanisms targeting HER2/neu-positive tumour cells. |
scientific article |
Statements
Characterisation of an engineered trastuzumab IgE antibody and effector cell mechanisms targeting HER2/neu-positive tumour cells (English)
Panagiotis Karagiannis
Josef Singer
James Hunt
Samuel K E Gan
Sarah M Rudman
Diana Mechtcheriakova
Regina Knittelfelder
Tracy R Daniels
Philip S Hobson
James Spicer
Frank O Nestle
Manuel L Penichet
Sophia N Karagiannis
22 October 2008
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference